Page last updated: 2024-09-03

cholecystokinin (27-33) and devazepide

cholecystokinin (27-33) has been researched along with devazepide in 1 studies

Compound Research Comparison

Studies
(cholecystokinin (27-33))
Trials
(cholecystokinin (27-33))
Recent Studies (post-2010)
(cholecystokinin (27-33))
Studies
(devazepide)
Trials
(devazepide)
Recent Studies (post-2010) (devazepide)
3900780542

Protein Interaction Comparison

ProteinTaxonomycholecystokinin (27-33) (IC50)devazepide (IC50)
Bile salt export pumpHomo sapiens (human)10
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0009
Gastrin/cholecystokinin type B receptorRattus norvegicus (Norway rat)0.0008
Cholecystokinin receptor type AHomo sapiens (human)0.0002
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.245
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.27

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Owyang, C; Song, I; Taylor, LP; Tsunoda, Y1

Other Studies

1 other study(ies) available for cholecystokinin (27-33) and devazepide

ArticleYear
Structure-activity function for binding and signaling in CHO-K1 and COS-7 cells expressing the cholecystokinin A receptor.
    Biochemical and biophysical research communications, 2004, Feb-13, Volume: 314, Issue:3

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Calcium; CHO Cells; COS Cells; Cricetinae; Devazepide; Inositol 1,4,5-Trisphosphate; Models, Molecular; Molecular Sequence Data; Peptide Fragments; Protein Binding; Radioligand Assay; Rats; Receptor, Cholecystokinin A; RNA, Messenger; Signal Transduction; Sincalide; Structure-Activity Relationship; Transfection

2004